Joint Pain News and Research

RSS

Scientists unveil how Zika virus replicates

The World Health Organization (WHO) declared the Zika virus infection a global threat during the peak of its outbreak in 2016. Since then, scientists and health experts raced to understand the virus better to develop novel and effective vaccines and treatments for the disease. Now, a team of researchers in China revealed how a protein in the virus reshapes its host to boost viral replication.

23 Dec 2019

New antibody shows promise in active lupus

A new trial involving the use of an antibody called anifrolumab reports improvement in patients with systemic lupus erythematosus (SLE) after 52 weeks of treatment. The research, titled 'Trial of Anifrolumab in Active Systemic Lupus Erythematosus', is published in the New England Journal of Medicine.

19 Dec 2019

An innovative treatment for joint pain

Tired of living with painful arthritic knees, 54-year-old Deborah Brown's interest was piqued when she saw a recruitment flyer for a clinical trial on an innovative pain treatment at The University of Texas Health Science Center at Houston (UTHealth).

18 Dec 2019

New paper-based test for early Lyme diagnosis

A new paper in the journal ACS Nano reports the development of an incredibly cheap and highly sensitive test to diagnose Lyme disease in its earliest stages, when it can be most easily, effectively and inexpensively treated.

18 Dec 2019

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

The results of a study conducted in Brazil suggest that the sympathetic nervous system - the part of the autonomous nervous system that controls responses to danger or stress - can modulate the action of defense cells in patients with autoimmune diseases.

16 Dec 2019

Patient-reported outcomes linked to aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to research findings to be presented Friday, Dec. 13 at the San Antonio Breast Cancer Symposium.

13 Dec 2019

ACA's new website aims to educate public about chiropractic services

The American Chiropractic Association has launched a new website to educate the public about non-drug pain relief and the chiropractic profession's holistic approach to health and improved function. HandsDownBetter.org is a resource for those who seek alternatives to pain medications and surgery for common musculoskeletal conditions such as back pain, neck pain, joint pain and headaches.

12 Dec 2019

Research uncovers mechanism that triggers inflammatory process by Mayaro virus

The mechanism by which defense cells respond to infection by Mayaro virus has been described by a team affiliated with the Center for Research on Inflammatory Diseases - CRID in an article published in the journal PLOS Pathogens.

2 Dec 2019

Only few nutritional supplements provide protection against cardiovascular disease

Store shelves are filled with nutritional supplements that promise to help with everything from joint pain to lowering cholesterol. Despite those claims, only three supplements have been shown to provide some protection against cardiovascular disease.

27 Nov 2019

Mercy Medical Center to establish the Maryland Bariatric Center

Noted bariatric specialist Kuldeep Singh, MD, FACS, MBA, FASMBS, has joined Mercy Medical Center to establish a new clinical program: The Maryland Bariatric Center at Mercy, scheduled to open in January 2020. Dr. Singh will lead the new center as Medical Director.

26 Nov 2019

New studies point to benefits of weight-loss surgery for teens with severe obesity

Severe obesity affects 4.5 million children and adolescents in the United States, according to the American Academy of Pediatrics.

19 Nov 2019

Rheumatoid arthritis: biologics useful in young and old alike

A new study presented at the 2019 ACR/ARP Annual Meeting says that all rheumatoid arthritis (RA) patients, irrespective of their age, benefit to a similar extent from the use of biologic drugs in their treatment. The study measured improvement in disease parameters 48 weeks after the beginning of therapy to establish this conclusion.

11 Nov 2019

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

11 Nov 2019

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.

11 Nov 2019

Biologics can be used effectively for both elderly-onset and young-onset RA patients

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

10 Nov 2019